SCAN-MP Study: High Prevalence of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals with Heart Failure
Key Points ATTR cardiac amyloidosis (ATTR-CA) is frequently diagnosed in older Black individuals with heart failure (HF), particularly in men over 75 years of age.... Read more.
A SUMMIT Analysis: Tirzepatide Reduces End Organ Damage in Patients with Obesity and HFpEF
Key Points SUMMIT, a randomized control trial of tirzepatide versus placebo in patients with HFpEF and obesity, found that tirzepatide significantly reduced the... Read more.
NUDGE-FLU Pool Analysis: Email Reminders Highlighting CV Benefits of Flu Shots Effective for Increasing Vaccine Uptake Post-MI
Key Points Three prior randomized trials including over two million adults in Denmark demonstrated that a variety of electronic message reminders, or “nudges”,... Read more.
ZODIAC: A Risk-based Decision Support System Did Not Significantly Improve Lipid-Lowering vs Usual Care
Key Points Maximizing lipid lowering therapy (LLTs) to optimize residual cardiovascular disease (CVD) risk after acute coronary syndrome (ACS) is usually a stepwise... Read more.
SUMMIT: Tirzepatide Decreased The Risk Of Worsening HF And CV Death in HFpEF + Obesity
Key Points SUMMIT was a multi-national trial that compared cardiovascular outcomes among patients with heart failure with preserved ejection fraction (HFpEF) and... Read more.
BPROAD: Intensive Blood Pressure Target Reduces MACE in Type 2 Diabetes
Key Points BPROAD was a randomized control trial in China that assigned nearly 13,000 participants with type 2 diabetes (T2DM) and hypertension (HTN) to either a... Read more.